title: Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches.
authors.affiliation: Wolfson Centre for Age-Related Diseases, King's College London, London, UK.
authors.forename: Anne
authors.initials: A
authors.lastname: Corbett
authors.affiliation: Wolfson Centre for Age-Related Diseases, King's College London, London, UK.
authors.forename: Clive
authors.initials: C
authors.lastname: Ballard
mesh_terms: D000544:Alzheimer Disease / Q000150:complications*; D003915:Dextromethorphan / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy*; D011802:Quinidine / Q000627:therapeutic use*
chemical_list: D003915:Dextromethorphan; D011802:Quinidine